CLL

You have access
Improved Survival of Patients With Chronic Lymphocytic Leukemia Between 1998-2022, Including the Era of Target Therapies With BCL2 and BTK Inhibitors
TAMAR TADMOR, GUY MELAMED, HILEL ALAPI, SIVAM GAZIT, TAL PATALON and LIOR ROKACH

Anticancer Research May 2024, 44 (5) 2109-2115; DOI: https://doi.org/10.21873/anticanres.17016
You have access
Expression of Surface-associated 82 kDa proMMP-9 in Lymphatic Leukemia Blast Cells Differentially Correlates With Prognosis
JOERG SCHMOHL, SABINE MOEBIUS, THOMAS GUENTHER, ELENA PEPELDJYIKA, CORINNA L. SEIDEL, WISHNU SUTANTO, FRIEDHELM SCHUSTER, DORIS KRAEMER, HELMUT SALIH, AMELY HARTMANN, JOHANNA TISCHER, CHRISTIAN RIES and HELGA SCHMETZER

Anticancer Research August 2021, 41 (8) 3891-3898; DOI: https://doi.org/10.21873/anticanres.15184
You have access
Cofilin-1 Maintains Prosurvival Signaling in Chronic Lymphocytic Leukemia Cells
MARTA KARP, AGNIESZKA KARCZMARCZYK, AGNIESZKA BOJARSKA-JUNAK, JOANNA PURKOT, MICHAŁ CHOJNACKI, MAŁGORZATA ZAJĄC, MACIEJ KORPYSZ, WALDEMAR TOMCZAK, MAREK HUS, MARTA MORAWSKA and KRZYSZTOF GIANNOPOULOS

Anticancer Research November 2020, 40 (11) 6327-6335; DOI: https://doi.org/10.21873/anticanres.14653
You have access
Paraoxonase 1 (PON1) Q192R and L55M Polymorphisms as Potential Predisposition Factors for Chronic Lymphocytic Leukemia
AGAPI IOANNIDOU, SOPHIA ZACHAKI, AGGELIKI DARAKI, IOANNA MARIA MARGARITI, DOMNA PANTELIA, PARASKEVI DIAMANTOPOULOU, CONSTANTINA SAMBANI, PARASKEVI ROUSSOU and KALLIOPI N. MANOLA

Anticancer Research June 2019, 39 (6) 2861-2869; DOI: https://doi.org/10.21873/anticanres.13415
You have access
The Frequency and Prognostic Value of Neutrophilia in Chronic Lymphocytic Leukemia
ILANA LEVY, ZAHAVA VADASZ, AARON POLLIACK and TAMAR TADMOR

Anticancer Research August 2018, 38 (8) 4731-4734; DOI: https://doi.org/10.21873/anticanres.12780
You have access
Lymphoma of the Cervix: Case Report and Review of the Literature
ZIAD HILAL, FRANZISKA HARTMANN, ASKIN DOGAN, CEM CETIN, HARALD KRENTEL, SVEN SCHIERMEIER, BEATE SCHULTHEIS and CLEMENS B. TEMPFER

Anticancer Research September 2016, 36 (9) 4931-4940;
You have access
Bendamustin–Rituximab Combination Is a Safe and Effective, Ambulatory Treatment for Elderly Patients with Chronic Lymphocytic Leukemia: Retrospective Real-world Analysis by Age from a German Registry and Review of the Literature
ULRICH RICHARD KLEEBERG, HARTMUT LINDE, GEORG GÜNTHER, HANS-WERNER TESSEN and MARKUS KERSTING

Anticancer Research June 2016, 36 (6) 2827-2838;
You have access
Genetics of Lymphocytes Influences the Emergence of Second Cancer in Chronic Lymphocytic Leukemia
MARTA BERNUÉS, MARIA ANTÒNIA DURÁN, GUIOMAR PUGET, JULIO IGLESIAS, PILAR GALÁN, FRANCISCO JAVIER VERCHER, JOAN BESALDUCH and JORDI ROSELL

Anticancer Research May 2014, 34 (5) 2311-2314;
You have access
Hodgkin's Variant of Richter Transformation in Chronic Lymphocytic Leukemia; A Retrospective Study from the Israeli CLL Study Group
TAMAR TADMOR, LEV SHVIDEL, NETA GOLDSCHMIDT, ROSA RUCHLEMER, RIVA FINEMAN, OSNAT BAIREY, NAOMI RAHIMI-LEVENE, YAIR HERISHANU, MONA YUKLEA, ARIELA ARAD, ARIEL AVIV and AARON POLLIACK

Anticancer Research February 2014, 34 (2) 785-790;

Main menu

User menu

Search

CLL